Skip to content

COMPARISON STUDY INJECTION HEAVY BUPIVACAINE 0.5% VS INJECTION HEAVY BUPIVACAINE 0.5% WITH FENTANYL IN LOWER ABDOMINAL AND LOWER LIMB SURGERIES

A Comparative Study of Hyperbaric Bupivacaine (0.5%) alone V/S Hyperbaric Bupivacaine (0.5%) with Fentanyl in spinal anaesthesia for lower Abdominal & lower extremity surgery (surgeries)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054076
Enrollment
80
Registered
2023-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: Fentanyl as an additive to bupivacaine: To determine the effects of intrathecally(route) administered fentanyl (25mcg) on hemodynamics (Blood Pressure, heart rate, duration of m

Sponsors

Anurag Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of age 18-60 years 2. American society of Anaesthesiologist (ASA) physical status I/II 3. Planned for elective surgery under Spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients refusing consent 2. Patients having local sepsis at site where spinal anesthesia is to given. 3. Patients with known bleeding or coagulation disorders 4. Patients with spinal deformity 5. Patients with Cardiopulmonary diseases 6. Patients with Neurological or psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Hyperbaric Bupivacaine 0.5% with Fentanyl in Spinal Anesthesia for Lower Abdominal & Lower Extremity Surgeries found to have longer duration of sensory and motor blockage then hyperbaric bupivacaine 0.5% aloneTimepoint: Primary outcome assessed in 6 weeks

Secondary

MeasureTime frame
Quality of subarachnoid block, hemodynamic stability, perioperative analgesia in patients undergoing for Lower Abdominal & Lower Extremity Surgeries are better in patients receiving bupivacine 0.5% with fentanyl as compared to patients receiving bupivacine 0.5% alone.Timepoint: Secondary outcome was assessed in 8 weeks

Countries

India

Contacts

Public ContactAnurag Agarwal

Varun Arjun Medical College

richanshu45@yahoo.co.in7080470075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026